|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 4 (February 15), 2000:
pp. 1435-1442
Three differentially expressed survivin cDNA variants
encode proteins with distinct antiapoptotic functions
Edward M. Conway,
Saskia Pollefeyt,
Jan Cornelissen,
Inky DeBaere,
Marta Steiner-Mosonyi,
Kelly Ong,
Mathijs Baens,
Désiré Collen, and
Andre C. Schuh
From the Departments of Medicine and the Institute of Medical
Science, University of Toronto, Toronto, Canada; Center for Transgene
Technology and Gene Therapy; Department of Human Genetics, Flanders
Interuniversity Institute for Biotechnology, University of Leuven,
Leuven, Belgium.
Survivin is a member of the inhibitor of apoptosis protein (IAP)
family that is believed to play a role in oncogenesis. To elucidate
further its physiologic role(s), we have characterized the murine
survivin gene and complementary DNA (cDNA). The structural organization of the survivin gene, located on chromosome 11E2, is similar to that of its human counterpart, both containing 4 exons.
Surprisingly, 3 full-length murine survivin cDNA clones were
isolated, predicting the existence of 3 distinct survivin proteins. The
longest open reading frame, derived from all 4 exons, predicts a
140-amino acid residue protein, survivin140, similar to
human survivin, which contains a single IAP repeat and a COOH-terminal coiled-coil domain that links its function to the cell cycle. A second
cDNA, which retains intron 3, predicts the existence of a 121-amino
acid protein, survivin121 that lacks the coiled-coil domain. Removal of exon 2-derived sequences by alternative
pre-messenger RNA (mRNA) splicing results in a third 40-amino acid
residue protein, survivin40, lacking the IAP repeat and
coiled-coil structure. Predictably, only recombinant
survivin140 and survivin121 inhibited caspase-3
activity. All 3 mRNA species were variably expressed during development
from 7.5 days postcoitum. Of the adult tissues surveyed, thymus and
testis accumulated high levels of survivin140 mRNA, whereas
survivin121-specific transcripts were detected in all
tissues, while those representing survivin40 were absent. Human counterparts to the 3 survivin mRNA transcripts were identified in a study of human cells and tissues. The presence of distinct isoforms of survivin that are expressed differentially suggests that
survivin plays a complex role in regulating apoptosis.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Letter in Blood Online:
-
Survivin does not inhibit caspase-3 activity
- Damon P. Banks, Janet Plescia, Dario C. Altieri, Jun Chen, Saul H. Rosenberg, Haichao Zhang, Shi-Chung Ng;, Edward M. Conway, Désiré Collen, and Andre Schuh
Blood 2000 96: 4002-4003.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
T. Mazoochi, M. Salehnia, S. Pourbeiranvand, M. Forouzandeh, S. J. Mowla, and E. Hajizadeh
Analysis of apoptosis and expression of genes related to apoptosis in cultures of follicles derived from vitrified and non-vitrified ovaries
Mol. Hum. Reprod.,
March 1, 2009;
15(3):
155 - 164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yue, A. Carvalho, Z. Xu, X. Yuan, S. Cardinale, S. Ribeiro, F. Lai, H. Ogawa, E. Gudmundsdottir, R. Gassmann, et al.
Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line
J. Cell Biol.,
October 20, 2008;
183(2):
279 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Angell
A study into the potential role of Survivin localization in resistance to drug-induced apoptosis
Bioscience Horizons,
June 1, 2008;
1(2):
85 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hu, Y. Shikama, I. Matsuoka, and J. Kimura
Terminally differentiated neutrophils predominantly express Survivin-2{alpha}, a dominant-negative isoform of Survivin
J. Leukoc. Biol.,
February 1, 2008;
83(2):
393 - 400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kindt, A. Menzebach, M. Van de Wouwer, I. Betz, A. De Vriese, and E. M. Conway
Protective role of the inhibitor of apoptosis protein, survivin, in toxin-induced acute renal failure
FASEB J,
February 1, 2008;
22(2):
510 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Eckelman and G. S. Salvesen
The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases
J. Biol. Chem.,
February 10, 2006;
281(6):
3254 - 3260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Caldas, M P Holloway, B M Hall, S J Qualman, and R A Altura
Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo
J. Med. Genet.,
February 1, 2006;
43(2):
119 - 128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Holleman, M. L. den Boer, R. X. de Menezes, M. H. Cheok, C. Cheng, K. M. Kazemier, G. E. Janka-Schaub, U. Gobel, U. B. Graubner, W. E. Evans, et al.
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia
Blood,
January 15, 2006;
107(2):
769 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Baratelli, K. Krysan, N. Heuze-Vourc'h, L. Zhu, B. Escuadro, S. Sharma, K. Reckamp, M. Dohadwala, and S. M. Dubinett
PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells
J. Leukoc. Biol.,
August 1, 2005;
78(2):
555 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Jiang, A. de Bruin, H. Caldas, J. Fangusaro, J. Hayes, E. M. Conway, M. L. Robinson, and R. A. Altura
Essential Role for Survivin in Early Brain Development
J. Neurosci.,
July 27, 2005;
25(30):
6962 - 6970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kumazawa, K. Kawamura, T. Sato, N. Sato, Y. Konishi, Y. Shimizu, J. Fukuda, H. Kodoma, and T. Tanaka
HCG up-regulates survivin mRNA in human granulosa cells
Mol. Hum. Reprod.,
March 1, 2005;
11(3):
161 - 166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Johnson and E. W. Howerth
Survivin: A Bifunctional Inhibitor of Apoptosis Protein
Veterinary Pathology,
November 1, 2004;
41(6):
599 - 607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Song, S. Liu, H. He, N. Hoti, Y. Wang, S. Feng, and M. Wu
A Single Amino Acid Change (Asp 53-> Ala53) Converts Survivin from Anti-apoptotic to Pro-apoptotic
Mol. Biol. Cell,
March 1, 2004;
15(3):
1287 - 1296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xing, E. M. Conway, C. Kang, and A. Winoto
Essential Role of Survivin, an Inhibitor of Apoptosis Protein, in T Cell Development, Maturation, and Homeostasis
J. Exp. Med.,
January 5, 2004;
199(1):
69 - 80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fukuda, C. R. Mantel, and L. M. Pelus
Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways
Blood,
January 1, 2004;
103(1):
120 - 127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Conway, F. Zwerts, V. Van Eygen, A. DeVriese, N. Nagai, W. Luo, and D. Collen
Survivin-Dependent Angiogenesis in Ischemic Brain: Molecular Mechanisms of Hypoxia-Induced Up-Regulation
Am. J. Pathol.,
September 1, 2003;
163(3):
935 - 946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. P. Blanc-Brude, M. Mesri, N. R. Wall, J. Plescia, T. Dohi, and D. C. Altieri
Therapeutic Targeting of the Survivin Pathway in Cancer: Initiation of Mitochondrial Apoptosis and Suppression of Tumor-associated Angiogenesis
Clin. Cancer Res.,
July 1, 2003;
9(7):
2683 - 2692.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Song, X. Yao, and M. Wu
Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis
J. Biol. Chem.,
June 13, 2003;
278(25):
23130 - 23140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. De Schepper, H. Bruwiere, T. Verhulst, U. Steller, L. Andries, W. Wouters, M. Janicot, J. Arts, and J. Van heusden
Inhibition of Histone Deacetylases by Chlamydocin Induces Apoptosis and Proteasome-Mediated Degradation of Survivin
J. Pharmacol. Exp. Ther.,
February 1, 2003;
304(2):
881 - 888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Temme, M. Rieger, F. Reber, D. Lindemann, B. Weigle, P. Diestelkoetter-Bachert, G. Ehninger, M. Tatsuka, Y. Terada, and E. P. Rieber
Localization, Dynamics, and Function of Survivin Revealed by Expression of Functional SurvivinDsRed Fusion Proteins in the Living Cell
Mol. Biol. Cell,
January 1, 2003;
14(1):
78 - 92.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Fukuda, R. G. Foster, S. B. Porter, and L. M. Pelus
The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34+ cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells
Blood,
September 18, 2002;
100(7):
2463 - 2471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Johnson, J. S. Langer, and J. T. Bridgham
Survivin as a Cell Cycle-Related and Antiapoptotic Protein in Granulosa Cells
Endocrinology,
September 1, 2002;
143(9):
3405 - 3413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fukuda and L. M. Pelus
Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis
Blood,
October 1, 2001;
98(7):
2091 - 2100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Silke and D. Vaux
Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis
J. Cell Sci.,
January 5, 2001;
114(10):
1821 - 1827.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Banks, J. Plescia, D. C. Altieri, J. Chen, S. H. Rosenberg, H. Zhang, S.-C. Ng;, E. M. Conway, D. Collen, and A. Schuh
Survivin does not inhibit caspase-3 activity
Blood,
December 1, 2000;
96(12):
4002 - 4003.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. R. Zaman and E. M. Conway
The elusive factor Xa receptor: failure to detect transcripts that correspond to the published sequence of EPR-1
Blood,
July 1, 2000;
96(1):
145 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Kasof and B. C. Gomes
Livin, a Novel Inhibitor of Apoptosis Protein Family Member
J. Biol. Chem.,
January 26, 2001;
276(5):
3238 - 3246.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|